|
|
|
|
|
![icon1](/img/s_history_icon1.gif) |
![icon2](/img/s_history_icon2.gif) |
¾àÇ°°Ë»ö |
![icon2](/img/s_history_icon2.gif) |
ºÎÀÛ¿ë ¹× ´ëó¹ý |
|
|
|
|
|
![](/img/medi_d_top.gif) |
|
¿À·Î»ìźÁ¤10/160mg Orosartan Tab. 10/160mg
|
Àü¹®ÀǾàÇ° | ±Þ¿©
|
|
|
![](/img/medi_d_icon.gif) |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàÇ° ÀÎÅÍ³Ý ÆǸŸ¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
¹àÀº Ȳ»öÀÇ Å¸¿øÇü Çʸ§ÄÚÆÃÁ¤ |
|
|
|
|
|
Á¦Á¶È¸»ç |
µ¿¾Æ¿¡½ºÆ¼(ÁÖ)
|
ÆǸÅȸ»ç |
µ¿¾Æ¿¡½ºÆ¼(ÁÖ)
|
Çã°¡Á¤º¸ |
Á¤»ó
(2013.07.30)
|
BIT ¾àÈ¿ºÐ·ù |
Ä®½·Ã¤³Î±æÇ×Á¦ / ¾ÈÁö¿ÀÅٽŠII ¼ö¿ëü ±æÇ×Á¦ (Calcium Channel Blockers and Angiotensin II Receptor Antagonists)
|
º¹ÁöºÎºÐ·ù |
214[Ç÷¾Ð°ÇÏÁ¦ ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
642506970 \1,002 ¿ø/1Á¤(2024.07.01)(ÇöÀç¾à°¡)\1,004 ¿ø/1Á¤(2022.05.04) (º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Valsartan and amlodipine / C09DB01 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]
![](/detail/img/sameIngredient.gif)
|
÷°¡Á¦ |
°æÁú¹«¼ö±Ô»ê,
¹«¼öÀλê¼ö¼ÒÄ®½·,
¹Ì°áÁ¤¼¿·ê·Î¿À½º,
½ºÅ׾Ƹ£»ê¸¶±×³×½·,
½ÃÆ®¸£»ê,
ÀúġȯµµÈ÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º,
Å©·Î½ºÄ«¸á·Î½º³ªÆ®·ý,
ÅÅÅ©,
È÷µå·Ï½ÃÇÁ·ÎÇʼ¿·ê·Î¿À½º
|
|
|
|
|
![](/img/medi_d_bottom.gif) |
|
|
|
|
Ç× ¸ñ |
³» ¿ë |
|
|
|
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2024-06-28 |
|
|
|
|
|
|
|
|
|